eHealth stock has a USD 2.19 target from six analysts

Published on 10/15/2026 at 19:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 33.57 million. eHealth stock costs EUR 0.53 on October 15, 2026, down 3.49 percent on Nasdaq versus USD 0.61.

Consensus target leads valuation

MarketBeat listed a USD 2.19 consensus target based on six analysts on October 14, 2026.
Second-quarter revenue reached USD 33.57 million on June 30, 2026.
eHealth stock costs EUR 0.53 at Lang & Schwarz on October 15, 2026 at 7:33 p.m. CEST, down 3.49 percent on Nasdaq versus USD 0.61.
The next estimated earnings date is November 4, 2026 before the market opens.

EHTH, US28238P1093, Illustration mit AI erstellt.

MarketBeat listed a USD 2.19 consensus target based on six analysts on October 14, 2026, putting the target 271.19 percent above Nasdaq's USD 0.59 quote. eHealth was at EUR 0.53 at Lang & Schwarz on October 15, 2026 at 7:33 p.m. CEST, while Nasdaq's quote was down 3.49 percent versus USD 0.61.

Second-quarter operating pressure

The latest reported quarter ended June 30, 2026. eHealth generated USD 33.57 million in revenue, down from USD 88.02 million in the first quarter, while consolidated net loss reached USD 23.60 million compared with USD 4.71 million in the prior quarter. InsiderTrades.com reported that the quarter's loss per share was USD 1.18 against a USD 0.84 consensus estimate, while revenue exceeded the USD 33.28 million estimate.

Nasdaq range starts at USD 0.58

Nasdaq quoted eHealth at USD 0.59 at 1:37 p.m. ET on October 15, 2026, with a USD 0.58 to USD 5.89 52-week range. The quote was down USD 0.02 from the USD 0.61 prior close, and volume was 273,376 shares against an average of 302,976. The company's market capitalization was USD 18.7 million.

Valuation and November date

The USD 2.19 consensus target is 271.19 percent above the USD 0.59 Nasdaq quote. The latest reported diluted earnings per share were negative USD 1.18 for the second quarter of 2026, leaving the trailing P/E ratio negative 0.66. MarketBeat estimates the next earnings announcement for November 4, 2026, before the market opens, with a conference call scheduled for 5:00 p.m. ET.

Comparison with peers

EHTH (Nasdaq, USD): minus 3.49 percent, P/E minus 0.66, market capitalization USD 18.7 million.
Clover Health (Nasdaq, USD): minus 2.61 percent, P/E minus 112.10, market capitalization USD 2.5 billion.
Oscar Health (NYSE, USD): minus 2.32 percent, P/E 23.92, market capitalization USD 8.7 billion.

Price and trading context

The Nasdaq quote and the euro indication point to a weak session for eHealth, while the company's latest quarterly figures provide the operating backdrop. The next scheduled earnings date places the next major company-specific checkpoint in November.

eHealth was at EUR 0.53 at Lang & Schwarz on October 15, 2026 at 7:33 p.m. CEST, with Nasdaq down 3.49 percent versus its USD 0.61 prior close. The further course of trading is shown by the continuously updated real-time quote of eHealth stock.